Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
Pastores
Gregory M
GM
New York University School of Medicine, Departments of Neurology and Pediatrics, New York, NY 10016, USA. Gregory.Pastores@nyumc.org